Dermata Therapeutics, Inc. (DRMA)
Nasdaq: DRMA · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2021
Who runs Dermata Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Proehl Gerald T
PRESIDENT, CHAIRMAN, CEO. First filing Aug 2021, latest Aug 18, 2026, 2 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
12 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Proehl Gerald T | PRESIDENT, CHAIRMAN, CEO | Aug 2021 | Aug 18, 2026 | none |
| Van Hoose Kyri K. | SVP, CFO | Sep 2021 | Aug 18, 2026 | none |
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Aug 2021 | Mar 17, 2026 | none |
| Nardo Christopher J. | Senior VP, CDO | Aug 2021 | Jan 6, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Scott Kathleen D. | director | Aug 2021 | Jun 16, 2026 | 1 · $0.00 |
| Bradrick Brittany | director | Jan 2022 | Jan 6, 2026 | none |
| Fisher Mary | director | Aug 2021 | Jan 6, 2026 | none |
| Hale David F | director | Aug 2021 | Jan 6, 2026 | none |
| Mento Steven J | director | Aug 2021 | Jan 6, 2026 | none |
| Sandler Andrew Seth | director | Aug 2021 | Jan 6, 2026 | none |
| Wierenga Wendell | director | Aug 2021 | Jan 6, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.